MARKET

ACIU

ACIU

AC Immune
NASDAQ
3.140
+0.180
+6.08%
After Hours: 3.140 0 0.00% 16:10 02/06 EST
OPEN
2.980
PREV CLOSE
2.960
HIGH
3.160
LOW
2.955
VOLUME
315.93K
TURNOVER
--
52 WEEK HIGH
4.000
52 WEEK LOW
1.430
MARKET CAP
315.29M
P/E (TTM)
-3.4916
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ACIU last week (0126-0130)?
Weekly Report · 6d ago
Weekly Report: what happened at ACIU last week (0119-0123)?
Weekly Report · 01/26 09:32
Weekly Report: what happened at ACIU last week (0112-0116)?
Weekly Report · 01/19 09:35
Weekly Report: what happened at ACIU last week (0105-0109)?
Weekly Report · 01/12 09:34
Weekly Report: what happened at ACIU last week (1229-0102)?
Weekly Report · 01/05 09:32
My Market Outlook For 2026: Focus On Pharma For Consistent Returns, Potential Skyrocketing Shares
Seeking Alpha · 12/29/2025 16:00
Weekly Report: what happened at ACIU last week (1222-1226)?
Weekly Report · 12/29/2025 09:31
Weekly Report: what happened at ACIU last week (1215-1219)?
Weekly Report · 12/22/2025 09:31
More
About ACIU
AC Immune SA is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on precision medicine for neurodegenerative diseases. It designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative indications, such as Alzheimer's disease (AD). The Company's pipeline includes nine therapeutic product candidates with five in clinical trials, and three diagnostic candidates. Its lead product candidate is Crenezumab, a humanized and monoclonal anti-Abeta antibody for Alzheimer’s disease. It has collaborations with pharmaceutical companies, including Roche/Genentech, Eli Lilly, Biogen, Janssen Pharmaceuticals, Nestle Institute of Health Sciences, Life Molecular Imaging (formerly Piramal Imaging) and Essex Bio-Technology.

Webull offers AC Immune SA stock information, including NASDAQ: ACIU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACIU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACIU stock methods without spending real money on the virtual paper trading platform.